Billy Joel Cancels Tour After Brain Condition Diagnosis
By I. Edwards HealthDay Reporter
TUESDAY, May 27, 2025 — Music legend Billy Joel has canceled tour dates through July 2026 after being diagnosed with a brain condition called normal pressure hydrocephalus (NPH).
The 76-year-old singer announced Friday that his condition had worsened with recent performances, affecting his hearing, vision and balance, CBS News reported.
"I'm sincerely sorry to disappoint our audience, and thank you for understanding," Joel said in a statement.
Doctors have advised him to stop performing for now and begin physical therapy. Joel said he’s hopeful he’ll return to the stage when he feels better.
Fans who bought tickets for any upcoming performances will receive automatic refunds.
Joel was originally scheduled to begin a new round of shows in July in Pittsburgh, with other stops across the U.S., Canada, and the U.K. He was set to perform with stars like Stevie Nicks, Rod Stewart and Sting, CBS News said.
NPH is a rare condition in which extra fluid builds up in or around the brain, putting pressure on brain tissue. This can lead to "trouble thinking, trouble walking and trouble with urinary incontinence," CBS News medical correspondent Dr. Jon LaPook said.
"Usually, it just comes out of the blue. We really don't know why," LaPook said.
The condition mostly affects older adults. The Cleveland Clinic says it affects about 0.2% of people in their 70s, and nearly 6% of those over 80.
"Getting prompt diagnosis and treatment helps improve your chances of a good outcome," Johns Hopkins notes on its website.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-05-28 06:00
Read more

- Poor Sleep Sign Of Brain Problems After Mild Stroke
- Birth Control Pill Increases Risk Of Asthma Attacks In Young Women
- Testosterone Use Not Tied to Gynecological Cancers in Transmasculine Individuals
- American College of Obstetricians and Gynecologists, May 16-18
- MRI-Guided Biopsy Linked to Durability of Active Surveillance in Prostate Cancer
- Want To Live Longer? Stay Sociable, Study Says
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions